• Scott L Simon, John M Abrahams, M Sean Grady, Peter D LeRoux, and Scott A Rushton.
• Department of Neurosurgery, the Hospital of the University of Pennsylvania, and the; Department of Orthopedic Surgery, Pennsylvania Hospital, Philadelphia, Pennsylvania, USA.
• Spine. 2002 May 15;27(10):E274-7.

Study DesignA case of iatrogenic intramedullary contrast injection during a C1-C2 cervical myelography is reported.ObjectiveTo investigate the occurrence of iatrogenic intramedullary contrast injection during a current C1-C2 cervical myelography.Summary Of Background DataIntramedullary injection of contrast is a rare but serious complication of C1-C2 cervical myelography that has not been reported since the widespread use of magnetic resonance imaging and the NASCIS III study protocol.MethodsA 39-year-old woman received an iatrogenic intramedullary contrast injection during a C1-C2 cervical myelography.ResultsDuring the procedure the patient reported right-side face, neck, and arm pain and parethesias. After the procedure, right arm weakness and diffuse hyperreflexia developed. Postmyelography imaging demonstrated intramedullary contrast and cord swelling. High-dose methylprednisolone was administered intravenously and the patient's symptoms improved. The literature and management of this rare complication are reviewed.ConclusionsIntramedullary cord injection is a rare complication of cervical myelography. The mechanism of spinal cord injury appears to involve a combination of physical compression from the injected liquid and neurotoxicity of the contrast material. Iohexol rather than metrizamide should be used when C1-C2 myelography is indicated in patients who are unable to undergo magnetic resonance imaging, or those whose pathology is inadequately demonstrated magnetic resonance imaging alone. In the event of contrast injection into the spinal cord, administration of high-dose methylprednisolone is recommended.

24 keywords...

hide…